日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer

低分子量褐藻糖胶作为结直肠癌氟嘧啶类化疗的补充疗法

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms22158041
Ching-Wen Huang, Yen-Cheng Chen, Tzu-Chieh Yin, Po-Jung Chen, Tsung-Kun Chang, Wei-Chih Su, Cheng-Jen Ma, Ching-Chun Li, Hsiang-Lin Tsai, Jaw-Yuan Wang
肿瘤
肠癌
发表日期：2021
文献求助 收藏

ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation

ERCC 过度表达与 cT4b 结直肠癌对 FOLFOX 为基础的新辅助同步放化疗反应不佳相关

期刊:Oncology Letters
影响因子:2.5
doi:10.3892/ol.2020.12075
Ming-Yii Huang, Hsin-Hua Lee, Ching-Wen Huang, Chun-Ming Huang, Cheng-Jen Ma, Tzu-Chieh Yin, Hsiang-Lin Tsai, Chee-Yin Chai, Yi-Ting Chen, Jaw-Yuan Wang
肿瘤
肠癌
发表日期：2020
文献求助 收藏

Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy

ERCC1、ERCC2 和 XRCC 表达对接受新辅助 mFOLFOX-4 化疗的局部晚期或转移性胃癌患者的预测价值

期刊:Pathology & Oncology Research
影响因子:2.3
doi:10.1007/s12253-019-00666-5
Yung-Sung Yeh, Yi-Ting Chen, Hsiang-Lin Tsai, Ching-Wen Huang, Cheng-Jen Ma, Wei-Chih Su, Chun-Ming Huang, Ming-Yii Huang, Huang-Ming Hu, Chien-Yu Lu, Jaw-Yuan Wang
肿瘤
胃癌
发表日期：2020
文献求助 收藏

EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function

Ⅲ期结直肠癌患者辅助化疗后EGFR表达及对癌细胞功能的影响

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.23072
Ching-Wen Huang, Yi-Ting Chen, Hsiang-Lin Tsai, Yung-Sung Yeh, Wei-Chih Su, Cheng-Jen Ma, Tsen-Ni Tsai, Jaw-Yuan Wang
肿瘤
肠癌
肿瘤细胞
发表日期：2017
文献求助 收藏